Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Interest Coverage Ratio (2023 - 2025)

Inhibrx Biosciences (INBX) has disclosed Interest Coverage Ratio for 3 consecutive years, with 10.63 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Coverage Ratio changed N/A to 10.63 in Q3 2025 year-over-year; TTM through Sep 2025 was 17.09, a 1.61% decrease, with the full-year FY2024 number at 24.57, down 256.83% from a year prior.
  • Interest Coverage Ratio was 10.63 for Q3 2025 at Inhibrx Biosciences, down from 8.72 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 5.62 in Q3 2023 to a low of 30.01 in Q2 2024.
  • A 3-year average of 12.89 and a median of 10.18 in 2023 define the central range for Interest Coverage Ratio.
  • Biggest YoY gain for Interest Coverage Ratio was 70.95% in 2025; the steepest drop was 75.7% in 2025.
  • Inhibrx Biosciences' Interest Coverage Ratio stood at 10.18 in 2023, then plummeted by 194.68% to 30.01 in 2024, then surged by 64.58% to 10.63 in 2025.
  • Per Business Quant, the three most recent readings for INBX's Interest Coverage Ratio are 10.63 (Q3 2025), 8.72 (Q2 2025), and 15.95 (Q1 2025).